Company
Estrella Immunopharma, Inc.
ESLA · CIK 0001844417
Acquisition (code M) of 100,000 shares at $0.815 per share.
Reporting Person Liu Cheng · Officer Title CEO · Transaction Code M
Traded Aug 25, 2026 · Disclosed Aug 26, 2026
Source: SEC Form 4 · 0001996255-26-000004 · filed 2026-08-26 · View filing →
Acquisition (code M) of 100,000 shares at $0.815 per share.
Reporting Person Xu Jiandong · Officer Title Chief Financial Officer · Transaction Code M
Traded Aug 18, 2026 · Disclosed Aug 25, 2026FILED +7 DAYS
Source: SEC Form 4 · 0001213900-26-093698 · filed 2026-08-25 · View filing →